Posttranscriptional Gene Regulation in Asthma
Posttranscriptional Gene Regulation in Asthma
批准号:
7659902
负责人:
ULUS ATASOY
金额:
$20.21万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-22 至 2011-04-30
关键词:
3&apos Untranslated RegionsAffectAllergensAllergicAnimal ModelAnimalsAreaAsthmaBindingBiologicalBiological AssayBoxingCD4 Positive T LymphocytesCell NucleusCloningComplexCytokine GeneCytoplasmDataDevelopmentDisabled PersonsDiseaseERG geneElementsEmployee StrikesExtrinsic asthmaFunctional disorderGene ExpressionGene Expression RegulationGene TargetingGenesGeneticGoalsHumanHypersensitivityIL13 geneImmunoprecipitationIndiumInflammationInflammatoryInflammatory ResponseInterferonsInterleukin-13Interleukin-4Knock-outLeadLentivirus VectorMessenger RNAMethodsModalityModelingMusOperonOutcomeOvalbuminOvumPathogenesisPatientsPhenotypePhysiciansPlayPrevalenceProductionProteinsPublic HealthPublishingRNA-Binding ProteinsRegulationReportingResearchResearch PersonnelRoleScientistSeveritiesT-Cell ActivationTestingTherapeuticTimeTissuesTranslationsUntranslated RegionsUp-RegulationWorkallergic airway inflammationbasecDNA Arrayschemokinecytokinedesignexperiencehandicapping conditionin vivoinnovationloss of functionmRNA Stabilitynovelnovel strategiespublic health relevanceresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Asthma has been increasing in prevalence and severity for unknown reasons. Though our understanding of the pathophysiology remains poor, it is widely accepted that asthma is an inflammatory disease and CD4+ T cells elaborating Th2 cytokines have been identified as major culprits in its development. Many of these genes are posttranscriptionally regulated but their regulation is not well understood. Current approaches have emphasized the use of microarrays to define "asthma signature genes". Though these approaches are helpful, they are also incomplete and may miss important target genes since there is a poor correlation between steady-state mRNA levels and protein production. We have developed a new paradigm, the posttranscriptional operon hypothesis, which states that RNA binding proteins are coordinately regulating the expression of biologically related molecules, such as those involved in T cell activation. Our central hypothesis is that the RNA binding protein, HuR, is coordinately regulating IL-4 and IL-13 cytokine genes during allergen driven asthma. The RNA binding protein, HuR, binds to the AU-rich elements (ARE) in the 3' untranslated regions (UTR) of mRNAs and modulates their stability and translation. The ARE motif is found in 8% of human genes and plays a critical role in posttranscriptional gene expression. In particular, two major Th2 cytokines, IL- 4 and IL-13, believed to play critical roles in allergen driven asthma, are regulated by HuR at the level of mRNA stability and translation. We have developed novel methods to identify en masse cellular in vivo HuR mRNA targets. Using these approaches, we have identified IL-4 and IL-13 as HuR targets. We will test this hypothesis with the following two specific aims: 1: Examine the effects of HuR modulation in CD4+ T cells upon IL-4 and IL-13 expression. 2: Assess the role of HuR in CD4+ T cells in allergen driven models of asthma in mice. Our approach will provide a fuller understanding of the regulation of proinflammatory cytokine genes involved in allergen driven asthma. Better understanding of proinflammatory gene regulation at posttranscriptional level may potentially lead to targeted therapies to treat asthma. Public Health Relevance: The rise of allergies and asthma around the world continues to perplex physicians and scientists. The reasons for this increase are unknown. Different responses to therapies for asthma are most likely due to differences in genetic backgrounds of patients. A better understanding of asthma pathophysiology at the posttranscriptional gene regulation level would greatly aid in our understanding of disease pathogenesis and treatment and have a direct impact on public health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of HuR Overexpression in Asthmatic Endotypes
-
批准号:10570322
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2023
-
负责人:ULUS ATASOY
-
依托单位:
Molecular mechanisms of posttranscriptional gene regulation in asthmatic airway inflammation
-
批准号:10698606
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:8090588
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2010
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:8070070
-
项目类别:
-
资助金额:$3.28万
-
财政年份:2010
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:7729032
-
项目类别:
-
资助金额:$28.33万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma and T Cell Differentiation
-
批准号:9225152
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma and T cell Differentiation
-
批准号:9590179
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:8107658
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
Posttranscriptional Gene Regulation in Asthma
-
批准号:7847589
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma and T Cell Differentiation
-
批准号:9021588
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:8307413
-
项目类别:
-
资助金额:$35.13万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:7912921
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
ADA AND PREMATURE TERMINATION CODONS
-
批准号:2057320
-
项目类别:
-
资助金额:$8.66万
-
财政年份:1994
-
负责人:ULUS ATASOY
-
依托单位:
ADA AND PREMATURE TERMINATION CODONS
-
批准号:2057319
-
项目类别:
-
资助金额:$8.52万
-
财政年份:1994
-
负责人:ULUS ATASOY
-
依托单位:
ADA AND PREMATURE TERMINATION CODONS
-
批准号:2057317
-
项目类别:
-
资助金额:$8.48万
-
财政年份:1994
-
负责人:ULUS ATASOY
-
依托单位:
NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM
-
批准号:3057547
-
项目类别:
-
资助金额:$3.08万
-
财政年份:1989
-
负责人:ULUS ATASOY
-
依托单位:
NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM
-
批准号:3057546
-
项目类别:
-
资助金额:$2.6万
-
财政年份:1988
-
负责人:ULUS ATASOY
-
依托单位:
NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM
-
批准号:3057545
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1987
-
负责人:ULUS ATASOY
-
依托单位:
海外基金